Literature DB >> 19655168

Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.

Kyung-Ok Uhm1, Jung Ok Lee, Yun Mi Lee, Eun Soo Lee, Hyeon Soo Kim, Sun-Hwa Park.   

Abstract

PURPOSE: Although the altered expression of integrin alpha4 is known to be associated with transformation or metastasis in several human cancers, the information on cholangiocarcinoma (CC) is still poor. In this study, we investigated the promoter methylation status of integrin alpha4 gene in CC.
METHODS: A total of 29 CC, 19 adjacent non-tumor-containing tissue and 15 normal liver specimens were used for identification of gene methylation status by methylation-specific polymerase chain reaction.
RESULTS: The frequency of DNA methylation was 55.17% (16 of 29) in the CC specimens (P < 0.001). Also, transcripts of the integrin alpha4 gene were decreased in all CC tissues in which there was DNA methylation of the integrin alpha4 gene. In addition, the downregulated expression of integrin alpha4 in CC cells with hypermethylation of the integrin alpha4 gene was restored by treatment with 5-aza-2'-deoxycytidine, a DNA methyltransferase inhibitor. Moreover, we found that DNA methylation of integrin alpha4 was detected in all CC tissues obtained from patients with LN metastasis (7/7). Furthermore, phosphorylation of paxillin, cell migration-related molecule, was regulated by silencing of integrin alpha4.
CONCLUSIONS: Taken together, these results suggest that loss of the integrin alpha4 gene is caused by aberrant DNA methylation of the 5'-CpG island site of the gene, and methylation of the integrin alpha4 gene can be a useful marker of metastasis of CC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655168     DOI: 10.1007/s00432-009-0646-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding.

Authors:  D G Kim; S Y Park; K R You; G B Lee; H Kim; W S Moon; Y H Chun; S H Park
Journal:  Genes Chromosomes Cancer       Date:  2001-01       Impact factor: 5.006

2.  Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.

Authors:  Janet C Lindsey; Meryl E Lusher; Gordon Strathdee; Robert Brown; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Int J Cancer       Date:  2006-01-15       Impact factor: 7.396

Review 3.  alpha 4 integrins and tumor metastasis.

Authors:  B Holzmann; U Gosslar; M Bittner
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

4.  Beta 1 integrin expression on human small cell lung cancer cells.

Authors:  L E Feldman; K C Shin; R B Natale; R F Todd
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

5.  Hypermethylation of the RASSF1A gene in gliomas.

Authors:  Yunxia Gao; Ming Guan; Bing Su; Weiwei Liu; Min Xu; Yuan Lu
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

6.  Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells.

Authors:  J Rincon; J Prieto; M Patarroyo
Journal:  Int J Cancer       Date:  1992-05-28       Impact factor: 7.396

7.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.

Authors:  Andrea Tannapfel; Florian Sommerer; Markus Benicke; Lars Weinans; Alexander Katalinic; Felix Geissler; Dirk Uhlmann; Johann Hauss; Christian Wittekind
Journal:  J Pathol       Date:  2002-08       Impact factor: 7.996

9.  Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.

Authors:  Riichiroh Maruyama; Kenji Sugio; Ichiro Yoshino; Yoshihiko Maehara; Adi F Gazdar
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860

10.  Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells.

Authors:  M M Zutter; S A Santoro; W D Staatz; Y L Tsung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  9 in total

1.  Aberrant DNA methylation of integrin α4 in human breast cancer.

Authors:  Sung-Im Do; Eunkyung Ko; So Young Kang; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho; Duk-Hwan Kim
Journal:  Tumour Biol       Date:  2014-04-24

2.  Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.

Authors:  Xie Zhang; Yu-Fei Song; Hong-Na Lu; Dan-Ping Wang; Xue-Song Zhang; Shi-Liang Huang; Bei-Lei Sun; Zhi-Gang Huang
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

3.  Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.

Authors:  Luydmila A Mostovich; Tatiana Y Prudnikova; Aleksandr G Kondratov; Dina Loginova; Pavel V Vavilov; Valentina I Rykova; Sergei V Sidorov; Tatiana V Pavlova; Vladimir I Kashuba; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

Review 4.  Epigenetic regulation and targeting of ECM for cancer therapy.

Authors:  Romi Gupta
Journal:  Am J Physiol Cell Physiol       Date:  2022-03-02       Impact factor: 4.249

5.  Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer.

Authors:  Daniela Cesselli; Antonio Paolo Beltrami; Alessandra Poz; Stefania Marzinotto; Elisa Comisso; Natascha Bergamin; Evgenia Bourkoula; Anja Pucer; Elisa Puppato; Barbara Toffoletto; Marisa Sorrentino; Umberto Baccarani; Claudio Avellini; Carlo Alberto Beltrami
Journal:  Int J Hepatol       Date:  2011-12-01

6.  Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.

Authors:  Ji Wook Moon; Soo Kyung Lee; Jung Ok Lee; Nami Kim; Yong Woo Lee; Su Jin Kim; Ho Jin Kang; Jin Kim; Hyeon Soo Kim; Sun-Hwa Park
Journal:  J Exp Clin Cancer Res       Date:  2014-01-06

7.  CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins.

Authors:  Mehdi Dehghani; Sedigheh Kianpour; Ana Zangeneh; Zohreh Mostafavi-Pour
Journal:  Int J Cell Biol       Date:  2014-12-15

8.  Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.

Authors:  Vladimir V Strelnikov; Ekaterina B Kuznetsova; Alexander S Tanas; Viktoria V Rudenko; Alexey I Kalinkin; Elena V Poddubskaya; Tatiana V Kekeeva; Galina G Chesnokova; Ivan D Trotsenko; Sergey S Larin; Sergey I Kutsev; Dmitry V Zaletaev; Marina V Nemtsova; Olga A Simonova
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

Review 9.  Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.

Authors:  Hege Marie Vedeld; Trine Folseraas; Guro Elisabeth Lind
Journal:  JHEP Rep       Date:  2020-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.